![EVALUATION OF THE EFFICACY, SAFETY, AND TOLERABILITY OF ORALLY ADMINISTERED BI 409306, A NOVEL PHOSPHODIESTERASE 9 INHIBITOR, IN TWO RANDOMIZED CONTROLLED PHASE II STUDIES IN PATIENTS WITH PRODROMAL AND MILD ALZHEIMER’S DISEASE]()
EVALUATION OF THE EFFICACY, SAFETY, AND TOLERABILITY OF ORALLY ADMINISTERED BI 409306, A NOVEL PHOSPHODIESTERASE 9 INHIBITOR, IN TWO RANDOMIZED CONTROLLED PHASE II STUDIES IN PATIENTS WITH PRODROMAL AND MILD ALZHEIMER’S DISEASEFrölich, Lutz; Wunderlich, Glen; Thamer, Claus; Roehrle, Michael; Garcia, Miguel; Dubois, Bruno · Alzheimer's & Dementia · 2018